مشاهدة "هام لمرضي السكري والكبد الدهني ومقاومة الانسولين/أدوية يجب الامتناع عنها فورا و اخري يجب ان تاخذها" على YouTube https://t.co/MOW20ydKhX
Reversible retinal vessel closure from VEGF-induced leukocyte plugging.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2021 – Aug 2023Where it's discussed
-
YouTube6 videos
-
News6 articles
-
X / Twitter3 posts
AI synopsis
What people are saying
Several discussions emphasize the mechanisms detailed in the publication, such as VEGF's role in blood vessel blockage, with users using words like 'important' and 'potential' to express their views, which demonstrates a moderate but meaningful engagement with the research and its implications.
Most posts reflect support or approval of the findings, emphasizing the importance of VEGF's role in retinal blood flow issues.
Discussions show moderate interest, with some users highlighting the significance of targeting leukocyte plugging in retinal diseases.
Posts include references to mechanisms such as VEGFR1 activation and VCAM1, indicating a decent level of engagement and understanding.
There is a sense that the research could influence future treatments, making it relevant to ongoing studies and potential clinical applications.
Abstract in brief
- The study explains that VEGF causes retinal vessels to become blocked by leukocytes, leading to decreased oxygen supply and worsening eye disease, but blocking VEGF can help reopen these vessels.
- It shows that VEGFR1 activation promotes leukocyte recruitment via VCAM1, and inhibiting these molecules can also reduce vessel blockage and improve blood flow.
- The findings suggest that early and sustained VEGF suppression, along with targeting VEGFR1 and VCAM1, could be effective strategies to prevent disease progression in conditions like diabetic retinopathy and retinal vein occlusion.
Top posts
Most liked on X and Blueskyهام جدا لمرضي السكري والكبد الدهني ومقاومة الانسولين/أدوية يجب الامتناع ... https://t.co/owMuUKTi8P عبر @YouTube
All mentions
Chromophore Treatment for Neural and Visual Defects in Diabetic Retinopathy
The study explores how a single chromophore administration alleviates neural defects in diabetic retinopathy, improving visual function and reducing oxidative stress in a mouse model.
Chromophore Therapy to Alleviate Neural Defects in Diabetic Retinopathy
A study shows that a single administration of a chromophore improves vision, reduces oxidative stress, and restores retinal cell health in diabetic retinopathy models.
Chromophore Treatment Improves Vision in Diabetic Retinopathy Patients
Diabetic retinopathy leads to vision loss before observable eye damage. A study using Akita mice showed that treatment with 9-cis-retinal improved visual function, reduced oxidative stress, and restored electrical…
Chromophore Treatment Improves Vision in Diabetic Retinopathy Patients
The single administration of a chromophore alleviates neural defects in diabetic retinopathy. The study with Akita mice shows that treatment with 9-cis-retinal improves visual function, reduces oxidative stress, and…
Advances in Treating Diabetic Retinopathy with VEGF Inhibitors and Chromophore Therapy
Injecting medications called vascular endothelial growth factor inhibitors into the eye helps stop abnormal blood vessel growth and reduce fluid buildup in diabetic retinopathy. Recent studies also suggest that…
DPP4 Enzyme's Role in Fatty Liver and Insulin Resistance Mechanisms
Increased hepatic DPP4 enzyme production promotes fatty liver disease and insulin resistance. Recent research shows elevated DPP4 is a cause, not just a consequence, of these conditions, offering potential targets for…
هام جدا لمرضي السكري والكبد الدهني ومقاومة الانسولين/أدوية يجب الامتناع ... https://t.co/owMuUKTi8P عبر @YouTube
هام لمرضي السكري والكبد الدهني ومقاومة الانسولين/أدوية يجب الامتناع عنها... https://t.co/Xgo4rHMxn3 via @YouTube
مشاهدة "هام لمرضي السكري والكبد الدهني ومقاومة الانسولين/أدوية يجب الامتناع عنها فورا و اخري يجب ان تاخذها" على YouTube https://t.co/MOW20ydKhX